Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
0.00%
DEBT TO ASSETS RATIO AVG 10Y
0.00%
DEBT TO ASSETS RATIO AVG 15Y
0.00%
DEBT TO ASSETS RATIO AVG 20Y
1.35%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
PharmaCyte Biotech, Inc.
Market Cap
$4.47M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.68M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.55M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.94M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.95M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.30M
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.04M
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. (PMCB) | $4.47M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.68M | 0.00% | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.60M | 0.00% | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 0.00% | N/A | N/A | N/A |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.94M | 0.00% | N/A | N/A | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.95M | 0.02% | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.30M | 0.37% | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.03M | 0.52% | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.04M | 0.49% | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.23M | 0.09% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
40.30
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | 0.00% |
| 2021-04-30 | 0.00% |
| 2021-01-31 | 0.91% |
| 2020-10-31 | 0.84% |
| 2020-07-31 | 1.01% |
| 2020-04-30 | 1.22% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | 0.00% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
| 2017-07-31 | 0.00% |
| 2017-04-30 | 0.00% |
| 2017-01-31 | 0.00% |
| 2016-10-31 | 0.00% |
| 2016-07-31 | 0.00% |
| 2016-04-30 | 0.00% |
| 2016-01-31 | 0.00% |
| 2015-10-31 | 0.00% |
| 2015-07-31 | 0.00% |
| 2015-04-30 | 0.00% |
| 2015-01-31 | 0.00% |
| 2014-10-31 | 0.00% |
| 2014-07-31 | 0.00% |
| 2014-04-30 | 0.00% |
| 2014-01-31 | 0.35% |
| 2013-10-31 | 9.14% |
| 2013-07-31 | 12.37% |
| 2013-04-30 | 14.60% |
| 2013-01-31 | 29.05% |
| 2012-10-31 | 18.13% |
| 2012-07-31 | 32.67% |
| 2012-04-30 | 100.23% |
| 2012-01-31 | 132.12% |
| 2011-10-31 | 137.16% |
| 2011-07-31 | 150.34% |
| 2011-04-30 | 191.27% |
| 2011-01-31 | 199.37% |
| 2010-10-31 | 201.73% |
| 2010-07-31 | 201.14% |
| 2010-04-30 | 198.21% |
| 2010-01-31 | 51.59% |
| 2009-10-31 | 39.85% |
| 2009-07-31 | 39.51% |
| 2009-04-30 | 41.04% |
| 2009-01-31 | 0.00% |
| 2008-10-31 | 0.00% |
| 2008-07-31 | 0.00% |
| 2008-04-30 | 0.00% |
| 2008-01-31 | 0.00% |
| 2007-10-31 | 0.00% |
| 2007-07-31 | 0.00% |
| 2007-04-30 | 0.00% |
| 2007-01-31 | 9.45% |
| 2006-10-31 | 10.87% |
| 2006-07-31 | 10.51% |
| 2006-04-30 | 9.89% |
| 2006-01-31 | 305.64% |
| 2005-10-31 | 1063.02% |
| 2005-07-31 | 922.73% |
| 2005-04-30 | 379.95% |
| 2005-01-31 | 325.35% |
| 2004-10-31 | 224.12% |
| 2004-07-31 | 119.76% |
| 2004-04-30 | 184.97% |
| 2004-01-31 | 12.79% |
| 2003-10-31 | 0.00% |
